Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Evosep Sign Codevelopment Agreement to Integrate LC-MS Technologies

NEW YORK (GenomeWeb) – Bruker and Evosep said today they have signed a codevelopment and comarketing agreement to integrate their mass spectrometry and liquid chromatography technologies.

Under the terms of the agreement, the companies will work to improve the integration of the Evosep One LC system with Bruker's timsTOF Pro mass spec by enabling control of both systems via Bruker's Hystar LC-MS control software. The agreement is focused on clinical proteomics research and the integrated Evosep One-timsTOF Pro system could enable analysis of more than 200 samples per day, the companies noted.

"We are excited about the collaboration and integration as the outstanding scan speed and sensitivity of the timsTOF Pro powered by PASEF is the perfect match for the short robust gradients with virtually no overhead that the Evosep One delivers," Nicolai Bache, Evosep's head of applications, said in a statement.